Augmented Reality & Virtual Reality In Healthcare Market Key Global Players & Recent Developments to 2028

Augmented Reality & Virtual Reality In Healthcare Industry Overview

The global Augmented Reality & Virtual Reality in healthcare market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 27.2% from 2021 to 2028. 

Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of the augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. These technologies have wide applications in healthcare including surgeries, diagnostics, rehabilitation, training, and education.

Augmented and virtual reality techniques are being increasingly adopted in surgeries and diagnostics. Systems such as touch surgery use virtual reality to provide a view of the patient’s anatomy and physiology, thereby providing opportunities for surgeons in the operating room, This, in turn, is expected to augment the growth of the market for augmented reality and virtual reality in healthcare. The growing adoption of Augmented Reality (AR) and Virtual Reality (VR) technologies in medical surgeries to optimize surgical procedures and increase the efficiency of treatment is one of the key factors driving market growth over the past few years. For instance, in December 2019, Augmedics launched the Xvision Spine AR guidance system for spine surgeries in the U.S. This solution allows the surgeon to view the 3D spinal anatomy of the patient during the surgery. Augmedics also received the U.S. FDA approval for Xvision in December 2019. Moreover, the increasing practice of storing medical images and patient data on the AR/VR platform helps in reducing requirements for expensive screens and unnecessary staff.

Gather more insights about the market drivers, restrains and growth of the Global Augmented Reality & Virtual Reality In Healthcare Market

Additionally, AR is being widely adopted for education and training purposes for medical personnel. Since AR-based learning modules provide anatomical visualization and simulation it gives the medical personnel a more wholesome complete learning experience. Moreover, these learning modules are even being used to train patients and help them understand the treatment flow and care management better. AR-based image visualization assists the surgeons and enhancing their accuracy and precision during complex surgeries. For instance, in February 2019 Philips Healthcare collaborated with Azurion and Microsoft to develop a mixed reality concept to provide a 3D holographic AR environment derived from multiple image modalities to assist surgeons.

During the outbreak of the COVID-19 pandemic, AR & VR in healthcare was influenced positively owing to the technological advancements in this space. For instance, in April 2020 XRHealth extended its application by raising USD 7 million to expand its telehealth platform. Similarly, Imperial College and St. Mary’s Hospital in London are using augmented reality glasses to visualize 3D imaging of blood vessels during reconstructive surgeries. Augmented reality and virtual reality in healthcare help in efficiently managing the treatment schedules, treatment delivery, and plans, and thereby it is anticipated to exponentially grow during the pandemic. Additionally, the decreasing costs in healthcare, rapid digitalization of healthcare, and improved delivery of effective health services are expected to drive growth. AR and VR in healthcare are gaining momentum due to widespread adoption in telemedicine, medical training & education, patient care management, medical marketing during the COVID-19 pandemic.

Furthermore, mergers and acquisitions, product development and launches, partnerships, and collaborative agreements are some of the crucial initiatives being undertaken by key players, which are expected to propel market growth. For instance, in January 2021 Hologic Inc acquired Biotheranostics, a molecular diagnostics company for USD 230 million. Through this acquisition, Hologic Inc and Biotheranostics will combine their capabilities and utilize their expertise in oncology diagnostics and advanced woman health diagnostics.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• Oncology Information Systems Market: The global oncology information systems market was valued at USD 2.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. Monumental growth of healthcare IT, the increasing global prevalence of cancer, increasing expenditure in development around treatment & solutions for cancer care, and increasing adoption of OIS solutions by healthcare facilities is some of the key factors anticipated to drive the growth of the market.

• Real World Evidence Solutions Market: The global real world evidence solutions market size was valued at USD 39.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. Support from regulatory bodies for using real world evidence (RWE) solutions and an increase in R&D spending are anticipated to boost the market growth. 

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware

• Software

• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Augmented Reality

• Virtual Reality

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Augmented Reality & Virtual Reality In Healthcare Market include

• CAE

• GE Healthcare

• Koninklijke Philips N.V.

• Intuitive Surgical

• Siemens Ltd

• Eon Reality, Inc

• Layar

• Bioflight VR

• WorldViz

• TheraSim Inc

• Mindmaze

Order a free sample PDF of the Augmented Reality & Virtual Reality In Healthcare Market Intelligence Study, published by Grand View Research. 

Hospital Information System Market to 2028 | Analysis, Competitive Landscape, Current and Future Trends

Hospital Information System Industry Overview

The global hospital information system market size was valued at USD 57.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2021 to 2028. 

Rising government initiatives and increasing demand from hospitals to deploy advanced IT solutions for effective operational efficiency are some of the key factors for the increase in the adoption of hospital information systems (HIS). The increasing need to reduce healthcare expenditure due to hospital workflow inefficiencies is expected to increase hospital information systems implementation worldwide. Thus, the growing demand for reduced healthcare costs and effective clinical outcomes is one of the key factors responsible for the adoption of information systems in developed economies and also in emerging economies, such as India, China, the Philippines, and Brazil.

Developing and developed regions are struggling to achieve high care delivery standards, which are both cost-effective and quality-oriented with minimum medical errors. With the help of HIS, providers are now able to streamline their workflows by offering enhanced patient outcomes about costs through investigational mining of electronic patient records for identifying inherent medical inaccuracies in the system. It enables them to offer cost-effective services to patients while reducing resources wastage. Moreover, increasing penetration of technologically advanced hospital management solutions is also aiding the market growth.

Gather more insights about the market drivers, restrains and growth of the Global Hospital Information System Market

The increased implementation of healthcare IT solutions and services by hospitals to provide enhanced patient care at reduced expenses, coupled with the growing need to upgrade already existing information systems, is likely to be a key driving factor. Moreover, consistent upgrades in healthcare and IT infrastructures along with increased adoption of cloud computing in hospital settings are also contributing significantly to the market growth. Since, healthcare data is subject to stringent regulatory oversight to ensure patient confidentiality, safe and secure storage, user-level authorization, traceability of information, and mitigation of other cybersecurity threats. Thus, hospitals are switching from on-premises deployments to cloud-based information systems to maintain high data security and avoid security breaches.

In addition, the growing adoption of EHR systems among developing economies owing to increased utilization of electronic health records for patient-centric care is expected to significantly boost the market growth over the next few years. EHR emerged as one of the key potential segments in hospital information systems, primarily owing to the rising demand for streamlining electronic healthcare solutions, technological advancements in healthcare information IT, and growing demand for EHR-integrated tools. Also, government initiatives promoting EHR are likely to propel the demand for electronic systems. EHRs offer a range of advantages to hospitals and patients, ultimately leading to increased system productivity and patient satisfaction.

Furthermore, associated benefits with these information systems, such as operational cost-reduction minimized errors in the end-use facility, and increased successful operational outcomes, are expected to propel market growth. Moreover, government initiatives supporting eHealth programs in developed as well as developing regions and incentives promoting information systems implementation in hospital settings in certain countries are further expected to drive the market over the forecast period.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• 5G In Healthcare Market: The global 5G in healthcare market size was valued at USD 34.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 34.5% from 2022 to 2030. The global market is driven by the rising adoption of robotic surgery and telehealth.

• Women’s Health App Market: The global women’s health app market size was valued at USD 2.7 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 19.45% from 2022 to 2030. The increasing incidence of diseases among women and the high penetration of smartphones is expected to drive the market growth. 

Hospital Information System Market Segmentation

Grand View Research, Inc. has segmented the global hospital information system market report on the basis of type, deployment, component, and region:

Hospital Information System Type Outlook (Revenue, USD Million, 2016 - 2028)

• Electronic health record

• Electronic medical record

• Real-time healthcare

• Patient engagement solution

• Population health management

Hospital Information System Deployment Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based

• On-premises

• Cloud-based

Hospital Information System Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software

• Hardware

• Services

Hospital Information System Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• MEA

Key Companies profiled:

Some prominent players in the Global Hospital Information System Market include

• Carestream Health

• Siemens Healthineers

• McKesson Corporation

• Philips Healthcare

• Merge Healthcare Inc. (IBM)

• GE Healthcare

• Cerner Corporation

• Allscripts

• NextGen Healthcare

Order a free sample PDF of the Hospital Information System Market Intelligence Study, published by Grand View Research. 

microRNA Market to 2028 | Key Global Players & Recent Developments and Their Impact on the Industry

microRNA Industry Overview

The global microRNA market size was valued at USD 854.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 19.8% from 2021 to 2028. 

Key trends that have collectively contributed to market growth over the years include emerging microRNA (miRNA) tools for disease-associated analytical applications, immense traction gained by miRNA target prediction and identification, and persisting wide adoption of the majority of the miRNA tools. Additionally, miRNAs are amongst the most important potential biopharmaceutical candidates that are entering in commercial space for developing potential future medicines.

Biopharmaceutical companies are increasingly engaging in the search for new therapeutic molecules that can act as new drugs which is further driving the market for microRNA. There are several miRNA-based candidates that are under clinical trials such as anti-miR compounds and specific inhibitors for miRNAs which can act as potential therapeutic solutions. Hence, RNA therapeutics is considered a trending investing area that will lead to the development of profitable drugs.

Gather more insights about the market drivers, restrains and growth of the Global microRNA Market

Increasing adoption of microRNA as a biomarker is driving the market. The miRNA biomarkers are of particular focus on genome-wide studies, and data-driven methodology, as they demonstrate high reproducibility and robustness when compared to traditional methods. Hence, they serve as promising candidates for the development of biomarkers. Moreover, the growing interest in liquid biopsies has further led to the increasing importance of miRNAs for biomarker discovery and development.

A steep increase in the research activities exploring the potential of miRNA biomarkers across prognosis, diagnosis, and therapeutics is expected to favor the market expansion in the near future. For instance, in January 2020, researchers explored the possibility of miRNA found in peripheral blood as a biomarker for diagnosing Bipolar II disorder (BD-II) using next-generation sequencing. miRNAs can be a possible noninvasive solution for the diagnosis of other neurodegenerative disorders.

In addition, the technological innovation for improving the sensitivity and selectivity of miRNA detection is further contributing to the growth of the market for microRNA. The newly developed methods for miRNA detection include nanoparticle-based amplification, RCA-based methods, DSN-based methods, LAMP-based methods, and enzyme-free amplification. Similarly, in January 2020, researchers developed a program-based isothermal amplification technique for specific and quantitative digital measurement of miRNA. The advantage of the system is that contamination is reduced by the fact that this system is dependent on the signal amplification process rather than direct replication of the targeted sequence, as it is done using PCR-based approaches.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• Genotyping Market: The global genotyping market was valued at USD 12.65 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2022 to 2030. The growth can be attributed to technological advancements, the rising prevalence of cancer & genetic disorders, and increasing R&D funding for precision medicine research. 

• Cell Culture Media Market: The global cell culture media market size was valued at USD 3,616.8 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. Cell culture media is generally a gel or liquid including compounds required to regulate and support the growth of cells or microorganisms used in the manufacturing of biopharmaceuticals.

microRNA Market Segmentation

Grand View Research has segmented the global microRNA market on the basis of products, services, application, end-use, and region:

microRNA Products Outlook (Revenue, USD Million, 2017 - 2028)

• Instruments

• Consumables

microRNA Services Outlook (Revenue, USD Million, 2017 - 2028)

• Service Type

• By Specimen

microRNA Application Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer

• Infectious Diseases

• Immunological Disorder

• Cardiovascular Disease

• Neurological Disease

• Others

microRNA End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Biotechnology & Pharmaceutical Companies

• Academic & Government Research Institutes

• Other end-users

microRNA Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global microRNA Market include

• Merck KGaA

• Thermo Fisher Scientific, Inc.

• Horizon Discovery Ltd.

• Synlogic

• QIAGEN

• GeneCopoeia, Inc.

• New England Biolabs

• Quantabio

• NanoString

• BioGenex

• SeqMatic LLC

• Miltenyi Biotec

• Sistemic Scotland Limited

• Biodynamics Laboratory Inc.

• OriGene Technologies, Inc.

Order a free sample PDF of the microRNA Market Intelligence Study, published by Grand View Research. 

Pneumatic Nebulizers Market to 2028 | Analysis, Competitive Landscape, Current and Future Trends

Pneumatic Nebulizers Industry Overview

The global pneumatic nebulizers market size was valued at USD 644.34 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% over the forecast period. 

The increasing incidence of chronic respiratory diseases, demand for home healthcare devices, and growing geriatric population are the factors expected to drive the market. According to statistics published by the CDC, approximately 18.4 million adults in the U.S. suffer from asthma. The COVID-19 pandemic has impacted all industries, including the pneumatic nebulizers market. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant about the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression.

Gather more insights about the market drivers, restrains and growth of the Global Pneumatic Nebulizers Market

However, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Therefore, the overall impact of COVID-19 on the market was minimal. Easy availability of compact pneumatic nebulizers ideal for home use, and technological innovations in these devices to reduce the sound created by them & improve their functionality, are increasing their adoption in-home healthcare. Moreover, these devices are favored by third-party payers, such as insurance companies, as they aim to reduce costs while providing quality healthcare services. These factors are expected to boost the adoption over the forecast period.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Corneal Implants Market: The global corneal implants market size was valued at USD 392.9 million in 2021 and is anticipated to register a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030. The increasing prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor propelling the industry's growth. 

• Wearable Injectors Market: The global wearable injectors market size was valued at USD 6.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2022 to 2030. The main market-driving factors are the prevalence of chronic illnesses, rising geriatric population, and growing concern over needle stick injuries.

Pneumatic Nebulizers Market Segmentation

Grand View Research has segmented the global pneumatic nebulizers market on the basis of the product, end-use, and region:

Pneumatic Nebulizers Product Outlook (Revenue, USD Million, 2016 - 2028)

• Breath-actuated

• Vented

Pneumatic Nebulizers End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics

• Home Healthcare

Pneumatic Nebulizers Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Pneumatic Nebulizers Market include

• Koninklijke Philips N.V.

• Omron Corp.

• PARI Pharma

• General Electric Company

• Allied Healthcare Products, Inc.

• BD (Becton, Dickinson & Company)

• GF Health Products, Inc.

• Medline Industries, Inc.

• Briggs Healthcare

• Vectura Group Plc

Order a free sample PDF of the Pneumatic Nebulizers Market Intelligence Study, published by Grand View Research. 

Intravenous Iron Drugs Market to 2028 | Growth Factors Analysis, Overview and Forecast Report

Intravenous Iron Drugs Industry Overview

The global intravenous iron drugs market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.5% from 2021 to 2028.

The growing prevalence of Chronic Kidney Disease (CKD), Inflammatory Bowel Disease (IBD), and cancer around the globe has led to an increase in the need for intravenous iron drugs for the treatment of subsequent Iron Deficiency Anemia (IDA), which is expected to propel market growth. Furthermore, approval and launch of novel formulations and strategic initiatives undertaken by key players to improve access to intravenous iron drugs are further expected to support market growth.

The COVID-19 outbreak has disrupted manufacturing and supply of intravenous iron drugs, however, robust initiatives by manufacturer and government to meet the demand has supported the growth of the market for intravenous iron drugs. In addition, various studies have suggested that Covid-19 infection has increased risk of Acute Kidney Injury (AKI) and CKD, which, in turn, has fueled the demand for intravenous iron drugs for the treatment of CKD-related anemia. According to the study published by the National Kidney Foundation, people hospitalized with COVID-19 are at significant risk of AKI. The study stated that patients hospitalized with COVID-19 were twice as likely to develop AKI as compared to non-COVID patients. Health authorities recommended that COVID-19 patients who had an AKI should be tested regularly as their risk of developing CKD is higher than others.

Gather more insights about the market drivers, restrains and growth of the Global Intravenous Iron Drugs Market

Anemia is one of the most common blood disorders in recent times. According to the National Heart, Lung, and Blood Institute, an estimated 3 million individuals suffer from anemia in the U.S. Increasing prevalence of target diseases, such as rheumatoid arthritis, autoimmune diseases, kidney conditions, cancer, liver disorders, thyroid diseases, and inflammatory bowel diseases, is a major factor facilitating the growth of the market for intravenous iron drugs. Some of the most common forms of anemia are iron and vitamin deficiency, a plastic, hemolytic, and sickle cell. Some of the common causes of anemia are iron, vitamin A and B12, and folate deficiencies. Infectious diseases such as tuberculosis, parasitic infections, malaria, and HIV are major causes of anemia across the globe. Data from WHO indicates that approximately 42% of children below the age of 5 and 40% of pregnant women are suffering from some form of anemia.

According to the National Kidney Foundation, Inc., the two major causes of CKD are diabetes and hypertension. Data from the same source also indicates an estimated 10% of the global population is affected by chronic kidney disease, with over 2 million individuals receiving dialysis on a regular basis. The majority of these individuals are typically seen across countries such as Italy, the U.S., Germany, Japan, and Brazil. A vast majority of individuals suffering from the disease are not aware until serious symptoms manifest. It is estimated that the incidence of chronic kidney cases will rise across developing economies, such as India and China, which implies an increase in the geriatric population over the coming years. With the growing prevalence of these diseases, the need for intravenous iron drugs has risen significantly.

One of the major drawbacks of oral iron drugs is their risk of severe adverse effects. Common adverse effects of oral iron drugs include digestive problems such as stomach aches, constipation, loss of appetite, nausea, and vomiting. The overdose of oral iron drugs may also induce convulsions, shallow or rapid breathing, tiredness or weakness, fatigue, pale skin, and bluish skin or fingernails. The use of intravenous iron drugs, on the other hand, has shown to bring about increased iron uptake by the body, facilitating Erythropoiesis-stimulating Agents (ESAs) to function in an enhanced manner to lower anemic conditions. Other advantages of intravenous iron drugs include the preservation of heart health and the ability to be used by dialysis patients, especially those undergoing hemodialysis. These adverse effects are, hence, anticipated to facilitate the switch to intravenous iron drugs, increasing the uptake of the same during the forecast period.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• Alopecia Market: The global alopecia market size was valued at USD 7.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028. The increasing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market. 

• Pharmaceutical Manufacturing Market: The global pharmaceutical manufacturing market size was valued at USD 405.52 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 11.34% from 2021 to 2028. The pharmaceutical landscape has undergone a massive transformation with the emergence of new technologies, cost-effective, and more efficient manufacturing approaches. 

Intravenous Iron Drugs Market Segmentation

Grand View Research has segmented the global intravenous iron drugs market on the basis of product, application, and region:

Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2016 - 2028)

• Iron Dextran

• Iron Sucrose

• Ferric Carboxymaltose

• Others

Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2016 - 2028)

• Chronic Kidney Disease

• Inflammatory Bowel Disease

• Cancer

• Others

Intravenous Iron Drugs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• MEA

Key Companies profiled:

Some prominent players in the Global Intravenous Iron Drugs Market include

• Vifor Pharma Management Ltd.

• AMAG Pharmaceuticals

• Daiichi Sankyo Company, Ltd. (American Regent. Inc.)

• Sanofi S.A.

• Pharmacosmos A/S

• Shield Therapeutics Plc

• AbbVie Inc. (Allergan Plc)

Order a free sample PDF of the Intravenous Iron Drugs Market Intelligence Study, published by Grand View Research. 

Fundus Cameras Market to 2028 | Leading Players Updates and Future Growth Analysis Report

Fundus Cameras Industry Overview

The global fundus cameras market size was valued at USD 303.2 million in 2020 and is expected to expand at a CAGR of 5.8% from 2021 to 2028. 

The increasing geriatric population and chronic disorders, such as diabetes and hypertension, are responsible for the growth in the incidence of retinal disorders. Key retinal disorders include Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Retinopathy of Prematurity (ROP). Furthermore, increasing awareness about eye disorders and the commercialization of several technologically advanced products are likely to propel the market during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Fundus Cameras Market

Diabetic eye diseases consist of a group of several eye conditions that include DR, diabetic macular edema, glaucoma, and cataract. According to the National Eye Institute (NEI), the U.S., the diabetic retinopathy patients in America are expected to double from 7.7 million in 2010 to 14.6 million in 2050. In addition, advancements in the field are expected to drive the market during the forecast period. COVID-19 has negatively impacted the market as the data captured during the pandemic was not accurate and sufficient to determine the eye problem. Lack of data limited the tracing of disease, its management, and treatment. However, handheld fundus cameras can be a useful option in this pandemic, as their portability will help in capturing the retinal changes in COVID patients present in different settings or locations.

Advancements from the digital camera, red-free fundus camera, film-based fundus camera to the development of other for clear and in-depth fundus imaging along with the growing adoption of these new technologies in emerging countries are anticipated to drive the market during the forecast period. Moreover, supportive government regulations are also expected to contribute to market growth. According to the laws and regulations of medical device agencies in the U.S. and Japan, the fundus imaging cameras must be replaced once in every 4 years. This law helps maintain the quality of instruments and, thereby, improves diagnosis and treatment. Hence, the law is likely to maintain the demand for devices in countries and boost the market.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Wearable Injectors Market: The global wearable injectors market size was valued at USD 6.66 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2022 to 2030. The main market-driving factors are the prevalence of chronic illnesses, rising geriatric population, and growing concern over needle stick injuries.

• Intrathecal Pumps Market: The global intrathecal pumps market size was valued at USD 325.6 million in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.  The rising incidence of chronic disorders, such as cancer, back pain, and chronic pancreatitis, is the major factor anticipated to drive the industry's growth. 

Fundus Cameras Market Segmentation

Grand View Research has segmented the global fundus cameras market based on product, end-use, and region:

Fundus Cameras Product Outlook (Revenue, USD Million, 2016 - 2028)

• Mydriatic Fundus Cameras

• Non-Mydriatic Fundus Cameras

• Hybrid Fundus Cameras

• ROP Fundus Cameras

Fundus Cameras End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals

• Ophthalmology Clinics

• Ophthalmic & Optometrist Offices

Fundus Cameras Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Fundus Cameras Market include

• Carl Zeiss Meditec, Inc.

• Kowa Company Ltd.

• Optomed Oy (Ltd.)

• Optovue, Incorporated

• CenterVue SpA

• NIDEK Co., Ltd.

• Topcon Medical Systems, Inc.

• Clarity Medical Systems, Inc.

• Canon, Inc.

Order a free sample PDF of the Fundus Cameras Market Intelligence Study, published by Grand View Research. 

Europe Passive Fire Protection Market to 2028 | Growth Factors Analysis, Overview and Forecast Report

Europe Passive Fire Protection Industry Overview

The Europe passive fire protection market size was valued at USD 1.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 3.7% from 2021 to 2028. Rising exploration activities along with technological advancements in the oil and gas industry are likely to drive market growth over the forecast period.

Rising consumer awareness regarding the benefits of firestops and fire barriers has boosted their installation in residential and commercial buildings, thereby driving the market. Increasing investments from oil and gas companies in Exploration and Production (E&P) activities and stringent regulations to make the drilling sites fire safe are likely to impact market growth positively.

Increasing government initiatives to encourage both developed and developing economies to improve the overall status of passive fire protection in buildings and industries is expected to drive the market over the forecast period. The stringency of fire safety regulations in Germany is expected to boost the investments in passive fire protection systems, thereby driving growth.

Gather more insights about the market drivers, restrains and growth of the Europe Passive Fire Protection Market 

Passive fire protection systems protect steel structures against fire by providing durability and strength to the structure. The safety of any passive fire protection system depends on the type of fire, duration, substrate type, material, and environmental conditions. The market has been witnessing rapid technological changes to improve the efficiency and quality of passive fire protection products.

Growing shale gas exploration activities due to improvements in exploration technologies, such as hydraulic and horizontal drilling coupled with its rising utilization in energy and manufacturing industries are likely to augment market growth over the coming years. Rising production activities in the European countries, including Russia, the U.K., Italy, and Norway, are expected to further propel the demand for passive fire protection products over the forecast period.

Several economies are focusing on the improvement of passive fire safety aspects of the existing and upcoming infrastructure owing to the increasing number of fire accidents along with loss of lives and assets. The European Union has made significant developments in enacting and reforming regulations to promote the health and safety of European citizens.

Browse through Grand View Research's Advanced Interior Materials Industry Research Reports.

• Advanced Composites Market: The global advanced composites market size was valued at USD 31.73 billion in 2021 and is expected to expand at a compounded annual growth rate (CAGR) of 9.2% from 2022 to 2030. Growing demand for the product in the aerospace and defense industry and sporting goods is expected to drive the market for advanced composites.

• Industrial Insulation Market: The global industrial insulation market size was estimated at USD 7.82 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of  5.0%. Increasing product demand for boosting process efficiency, condensation control, noise reduction, freeze protection, and reducing environmental pollution is expected to drive market growth during the forecast period. 

Europe Passive Fire Protection Market Segmentation

Grand View Research has segmented the Europe passive fire protection market on the basis of product, end-use, and country:

Europe Passive Fire Protection Product Outlook (Revenue, USD Million, 2017 - 2028)

• Cementitious Materials

• Intumescent Coatings

• Fireproofing Cladding

• Others

Europe Passive Fire Protection End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Oil & Gas

• Construction

• Industrial

• Warehousing

• Others

Europe Passive Fire Protection Country Outlook (Revenue, USD Million, 2017 - 2028)

• Czech Republic

• France

• Germany

• Italy

• Poland

• Romania

• Russia

• Spain

• U.K.

Key Companies profiled:

Some prominent players in the Europe Passive Fire Protection Market include

• 3M

• RPM International Inc.

• Hempel A/S

• The Sherwin-Williams Company

• Hilti

• Mercor Tecresa

• Etex Group

• Rudolf Hensel GmbH

• Rolf Kuhn GmbH

Order a free sample PDF of the Europe Passive Fire Protection Market Intelligence Study, published by Grand View Research.